RemSleep Holdings (RMSL) Net Cash Flow Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 25.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.96% |
| Sep 30, 2025 | 32.33% |
| Jun 30, 2025 | 61.67% |
| Mar 31, 2025 | -58.87% |
| Dec 31, 2024 | -27.45% |
| Sep 30, 2024 | -26.93% |
| Jun 30, 2024 | -29.39% |
| Mar 31, 2024 | -36.33% |
| Dec 31, 2023 | -133.03% |
| Sep 30, 2023 | -77.83% |
| Jun 30, 2023 | -22.93% |
| Mar 31, 2023 | -68.84% |
| Dec 31, 2022 | -170.68% |
| Sep 30, 2022 | -42.65% |
| Jun 30, 2022 | -139.85% |
| Mar 31, 2022 | 183.44% |
| Dec 31, 2021 | 252.86% |
| Sep 30, 2021 | 267.97% |
| Jun 30, 2021 | 78.77% |
| Mar 31, 2021 | -3.86% |
| Dec 31, 2020 | 107.05% |
| Sep 30, 2020 | 152.36% |
| Jun 30, 2020 | -309.45% |
| Sep 30, 2019 | -1,782.67% |
| Jun 30, 2019 | 1,241.23% |
| Mar 31, 2019 | 793.18% |
| Dec 31, 2018 | -41.78% |
| Dec 31, 2017 | -39.02% |
| Sep 30, 2016 | 75.12% |
| Jun 30, 2016 | 95.97% |
| Mar 31, 2016 | -29.58% |
| Dec 31, 2015 | 53.84% |
| Dec 31, 2014 | 30.42% |